Quantitative Whole-Body MRI

In his Editorial “Advancing Cancer Care with Modern MRI” Professor Padhani points out that many aspects of cancer care remain on ‘red alert’ as we enter the second decade of the 21st century. There are many times when healthcare professionals cannot confidently answer questions that directly affect patient care. Seemingly simple questions such as “Do I have cancer?”, “Is the cancer going to kill me?”, “Is my cancer responding to therapy?”, “Is the cancer back?” and “How long do I have to live?”, “Will I make it to my daughter’s wedding?” evade us on a daily basis. While we struggle to respond to the needs of our patients, we remain aware that progress is being made every day in cancer diagnosis and therapy, and within this, is the role being played by MRI as highlighted by articles and videos on this page.


Application Tips

Whole-body MRI at 1.5T: step-by-step video tutorial

Will McGuire, Deputy Superintendent Radiographer, Paul Strickland Scanner Centre, Northwood, Middlesex, UK 

Whole-body MRI has been used as a clinical tool at Paul Strickland Scanner Centre fo over 10 years. In that time they have performed over 6500 examinations, using a protocol designed to enable the detection and surveillance of metastatic bone and soft tissue disease. Will McGuire, Linda Culver and Anwar R. Padhani share their .exar1 protocol file exported from a MAGNETOM Avantofit running software version syngo MR E11C.

Whole-body MRI at 1.5T: step-by-step

Will McGuire, Deputy Superintendent Radiographer, Paul Strickland Scanner Centre, Northwood, Middlesex, UK

How-I-do-it: Whole-body MRI including DWI

David Hillier, MR Application Specialist, Siemens Healthineers Great Britain and Ireland
 

Frequently Asked Questions: Diffusion-Weighted Imaging

Joachim Graessner, Dipl. Ing., Siemens Healthineers, Hamburg, Germany
 


Clinical Talks and Articles

Watching Cancer Develop Multidrug Resistance

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK

Quantitative WB-MRI with ADC Histogram Analysis for Response Assessment in Diffuse Bone Disease

Danoob Dalili, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK
Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK

Quantitative WB-MRI with ADC Histogram Analysis for Complex Response of Bone Marrow Metastatic Disease

Danoob Dalili, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK
Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK

Evolution of the Malignant Bone Marrow with Successful Therapy – Quantitative Analysis with Whole-body Diffusion-weighted MRI

Danoob Dalili, Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK
Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
Priya V. Joshi, Mount Vernon Cancer Centre and the East and North Herts NHS trust hospitals, Northwood, Middlesex, UK

Whole-body Diffusion-weighted MRI: The Time has Come for a Change

Atul Kapoor, Goldaa Mahajan, Aprajita Kapoor, Department of Radiology and Magnetic Resonance Imaging, Advanced Diagnostics Amritsar, Punjab, India

Observing Endocrine Therapy Resistance in Metastatic Breast Cancer with Whole-body MRI

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Metastatic Prostate Cancer in Practice The MET-RADS-P Imaging Response System Using Whole-body MRI

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
Nina Tunariu, Royal Marsden NHS Foundation Trust & Institute of Cancer Research and Cancer Research UK Cancer Imaging Centre, Sutton, Surrey, UK
 

Monitoring Bone Marrow Metastases Treatment with Whole-Body Diffusion MRI

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Whole Body Diffusion-Weighted MRI for Bone Marrow Tumor Detection

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

Initial Experience with Whole-Body Diffusion-Weighted Imaging in Oncological and Non-Oncological Patients

Leonardo Kayat Bittencourt, Clínica de Diagnóstico por Imagem, Rio de Janeiro, Brazil
 

Whole-Body Diffusion-Weighted MRI of the Bone Marrow in Health and Disease

Anwar R. Padhani, Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
 

18F-FDG PET/MR: Its Incremental Value in Assessing the Multiple Myeloma Patient

Shetal N. Shah, M.D., Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA
 

Hybird PET/MR Imaging with PSMA-Ligands: The Future Standard in the Diagnosis of Prostate Cancer?

Ali Afshar-Oromieh, M.D., Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
 

Combining [18F] PET with MR for Detection of Bone Metastases in One Simultaneous Examination

Markus Lentschig, CEMODI, Centre for Modern Diagnostics, Bremen, Germany
 


Product News

Whole-body Diffusion-weighted MR Image Analysis with syngo.via Frontier MR Total Tumor Load

Robert Grimm, Siemens Healthineers, Erlangen, Germany
 

Whole-body MR Image Reading and Bone Assessment with syngo.via Frontier MR Bone Scan

Matthias Fenchel, Siemens Healthineers, Erlangen, Germany